Denise Carter 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 4:43 pm Purchase | 2025-01-27 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Denise Carter | 939,238 4.900% | 316,825 (+50.90%) | Filing |
| 2025-01-02 5:20 pm Purchase | 2024-12-23 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Denise Carter | 622,413 6.900% | 622,413 (New Position) | Filing |